CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) EV-to-EBITDA : -1.02 (As of May. 28, 2024)

CTT Pharmaceutical Holdings EV-to-EBITDA Chart

CTT Pharmaceutical Holdings Annual Data
	Trend	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15
EV-to-EBITDA		Get a 7-Day Free Trial					-9.06	-0.30	-0.40	-14.33	-0.35

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
EV-to-EBITDA	Get a 7-Day Free Trial															-1.04	-21.03	-10.52	-28.58	-15.19

Competitive Comparison of CTT Pharmaceutical Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTT Pharmaceutical Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's EV-to-EBITDA falls into.

CTT Pharmaceutical Holdings EV-to-EBITDA Calculation

CTT Pharmaceutical Holdings's EV-to-EBITDA for today is calculated as:

CTT Pharmaceutical Holdings's current Enterprise Value is $1.21 Mil.
CTT Pharmaceutical Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTT Pharmaceutical Holdings  (OTCPK:CTTH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CTT Pharmaceutical Holdings's PE Ratio for today is calculated as:

CTT Pharmaceutical Holdings's share price for today is $0.0249.
CTT Pharmaceutical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

CTT Pharmaceutical Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description